$KYNB

$4.65 -$0.07 (1.48%) Close

$KYNB Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 4.0M shares outstanding

Who owns KYNB?

By type of holder

Institutions 24.7% Insiders 1.3% Everyone else 74.0%

Concentration Top 10 holders own 23.1%

Armistice Capital, LLC 9.9% · Vanguard Capital Management LLC 4.0%

Institutional ownership

24.7%

-0.9 pts vs last qtr

Institutional holders

-5 vs last qtr

Net shares bought

−35.7K

by institutions in Q2 2026

New / sold out

1 / 6

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Gsa Capital Partners LLP NEW +15.7K
Vanguard Capital Management LLC +3.3K

Biggest sellers in Q2 2026

UBS Group AG −19.7K
Jane Street Group, LLC SOLD OUT −12.2K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Kyntra Bio, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2020–FY2025

+12.5%

+2.38% a year

Each share's claim on the business

−11.1%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $292M

over 6 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years42% 3–5 years40% 1–3 years14% Under 1 year4%

Quarterly turnover

3.7%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting KYNB on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
AC Armistice Capital, LLC	400.0K	9.88%	Unchanged	2022	0.0%
Shares held by quarter Peak holding8.5M (Q1'25) Change over 8 quarters−6.4M Share of the company9.880% Armistice Capital, LLC's full portfolio →
VC Vanguard Capital Management LLC	160.0K	3.95%	+3.3K (+2.1%)	≤2021	0.0%
Shares held by quarter Peak holding160.0K (Q2'26) Change over 8 quarters+160.0K Share of the company3.950% Vanguard Capital Management LLC's full portfolio →

Armistice Capital, LLC

400.0K

% of company

9.88%

Change vs last qtr

Unchanged

Held since

2022

Vanguard Capital Management LLC

160.0K

% of company

3.95%

Change vs last qtr

+3.3K (+2.1%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding Kyntra Bio, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting KYNB on Form N-PORT; together they hold 4.9% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$862K	114.2K	2.82%	0.00%	June 30, 2026
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$319K	42.3K	1.04%	0.00%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$862K

% of company

2.82%

% of the fund

0.00%

As of

June 30, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$319K

% of company

1.04%

% of the fund

0.00%

As of

June 30, 2026

8 more funds behind a free account

See every fund holding Kyntra Bio, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
WT Wettig Thane Insider	26.8K	0.66%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.660% Wettig Thane's insider activity →
CC Chung Christine Insider	11.8K	0.29%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.290% Chung Christine's insider activity →

Wettig Thane

Insider

26.8K

% of company

0.66%

Change vs last qtr

—

Held since

—

Chung Christine

Insider

11.8K

% of company

0.29%

Change vs last qtr

—

Held since

—

3 more holders behind a free account

See every insider and 5%+ holder of Kyntra Bio, Inc..

Comments